Deborah M. Messemer - Jun 13, 2023 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role
Director
Signature
/s/Lillian Smith, Attorney-in-Fact
Stock symbol
ALLO
Transactions as of
Jun 13, 2023
Transactions value $
$0
Form type
4
Date filed
6/15/2023, 05:06 PM
Previous filing
May 26, 2023
Next filing
Jul 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALLO Common Stock Award $0 +74.6K +1140.95% $0.00 81.1K Jun 13, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.